Mindset Pharma Performance
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Mindset Pharma are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Mindset Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Mindset Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 6.6 M | |
| Free Cash Flow | 385.6 K |
Mindset |
Mindset Pharma Relative Risk vs. Return Landscape
If you would invest (100.00) in Mindset Pharma on November 10, 2025 and sell it today you would earn a total of 100.00 from holding Mindset Pharma or generate -100.0% return on investment over 90 days. Mindset Pharma is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than Mindset, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Mindset Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mindset Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mindset Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mindset Pharma is not yet fully synchronised with the market data | |
| Mindset Pharma has some characteristics of a very speculative penny stock | |
| Mindset Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 3.91 M. Net Loss for the year was (16.61 M) with profit before overhead, payroll, taxes, and interest of 3.91 M. |
Mindset Pharma Fundamentals Growth
Mindset OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Mindset Pharma, and Mindset Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mindset OTC Stock performance.
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 9.77 M | |||
Things to note about Mindset Pharma performance evaluation
Checking the ongoing alerts about Mindset Pharma for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Mindset Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mindset Pharma is not yet fully synchronised with the market data | |
| Mindset Pharma has some characteristics of a very speculative penny stock | |
| Mindset Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 3.91 M. Net Loss for the year was (16.61 M) with profit before overhead, payroll, taxes, and interest of 3.91 M. |
- Analyzing Mindset Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mindset Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Mindset Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mindset Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mindset Pharma's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Mindset Pharma's otc stock. These opinions can provide insight into Mindset Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in poverty. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |